Image placeholder title

Bempegaldesleukin Precision Cancer Medicine for Melanoma

FDA grants "Breakthrough Therapy Designation" for Bempegaldesleukin + Opdivo for previously untreated advanced Melanoma

Image placeholder title

Opdivo - Yervoy Immunotherapy Prolongs Survival in Advanced Melanoma

5 year follow up continues to demonstrate Yervoy + Opdivo superiority-better understanding of side effects is emerging.

Image placeholder title

Tumor-Infiltrating Lymphocyte Therapy for Melanoma

Tumor Infiltrating Lymphocyte "TIL" therapy is a promising immunotherapy for advanced melanoma. ASCO 2020 update.

Melanoma Treatment